_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Welcome to the British Society for Haematology event page. Below you can access recordings from the Novartis-sponsored sessions which took place at the BSH Annual Scientific meeting on 25th – 28th April 2021. You will be able to access full recordings from the symposia, as well as some highlights, enabling you to watch footage whenever it is convenient for you.

First drop down link – under the title 'The burden of vaso-occlusive crises in patients with sickle cell disease'. Video. Preview with title 'The burden of vaso-occlusive crises in patients with sickle cell disease'.

The burden of vaso-occlusive crises in patients with Sickle Cell Disease 

In this symposium, Consultant Haematologist Professor Jo Howard takes a look at the pathophysiology of sickle cell disease (SCD) and the impact that vaso-occlusive crises have on all aspects of patient’s lives. She offers management strategies for pain associated with SCD and evaluates some of the emerging therapies as of April 2021.

Access symposium recordings

 

 

Second drop down link – under the title 'I-Wish to improve HCP-patient dialogue'. Video. Preview with title 'I-Wish to improve HCP-patient dialogue.'

I-WISh to improve the HCP-patient dialogue

Global experts leading the immune thrombocytopenia (ITP) World Impact Survey (I-WISh) discuss results of certain aspects of the survey and how these can be used to help patients with ITP. Topics include the impact of ITP both globally and with a focus on patients in the UK, how it affects paediatric patients, how best to understand and connect with ITP patients and a round-table discussion on defining treatment success beyond platelet count.

Access symposium recordings

 

 

Third drop down link – under the title 'MPN: The importance of the MDT in patient management'. Video. Preview 'Myeloproliferative Neoplasms: The importance of the MDT in patient management'.

MPN: The importance of the MDT in patient management

Consultant Haematologist Professor Claire Harrison, Clinical Nurse Specialist Claire Woodley, Specialist Occupational Therapist Lauren Urwin and Specialist Oncology Physiotherapist Toni Wyatt discuss the impact of myeloproliferative neoplasms (MPN) on patients from both the patient’s and haematologist’s perspective, before demonstrating the importance of the multidisciplinary team (MDT) in helping patients achieve symptom management by offering the view from a nurse specialist and the MDT. The symposium includes insights from 3 MPN patients too.

Access symposium recordings

 

 

UK | 121933 | April 2021
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]